Werewolf Therapeutics, Inc. · NASDAQ:HOWL
Luke Evnin sold 139,803 Werewolf Therapeutics, Inc. shares (Form 4)
Traded Jun 1 to Jun 3, 2026 · Filed Jun 3, 2026
From Jun 1 to Jun 3, 2026, Luke Evnin (Director) sold 139,803 Werewolf Therapeutics, Inc. shares at an average US$0.46 for US$63,628 under a trading plan, leaving 482,776 shares. Filed Jun 3, 2026 (Form 4).
- Sold
- 139,803 shares
- Price
- US$0.46 average (US$0.42 to US$0.47)
- Value
- US$63,628
- Holding after
- 482,776 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | Sale | 80,459 | US$0.47 | 542,120 | Indirect |
| Jun 2, 2026 | Common Stock | Sale | 29,595 | US$0.45 | 512,525 | Indirect |
| Jun 3, 2026 | Common Stock | Sale | 29,749 | US$0.42 | 482,776 | Indirect |
Source
Related
- Werewolf Therapeutics, Inc.
- Luke Evnin
- Werewolf Therapeutics, Inc. shareholders
- Form 4 · Luke Evnin · Jul 8, 2026
- Form 4 · Luke Evnin · Jun 29, 2026
- Form 4 · Luke Evnin · Jun 10, 2026
- Form 4 · Luke Evnin · Jun 8, 2026
- Form 4 · Luke Evnin · May 29, 2026
- Schedule 13G · Moll Peter · Sep 21, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jul 2, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jun 26, 2026
- Form 4 · Ra Capital Management, L.P. · Jun 22, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jun 22, 2026